Petros Pharmaceuticals, Inc. (PTPI) Net margin 2020–2024
Petros Pharmaceuticals, Inc. (PTPI) net profit margin by fiscal year — reported net income divided by reported revenue.
-280.1%FY2024 · since FY2020: -215.3% → -280.1%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2024 | -280.1% | -139.9 pp |
| FY2023 | -140.2% | +194.2 pp |
| FY2022 | -334.4% | -219.4 pp |
| FY2021 | -115.0% | +100.3 pp |
| FY2020 | -215.3% | — |
Net margin = reported net income ÷ reported revenue for the same fiscal year. Loss years show as a negative margin.
Source: SEC XBRL filings · For reference only · Not investment advice
More PTPI financial trends
PTPI RevenuePTPI Net incomePTPI Gross profitPTPI Gross marginPTPI Operating incomePTPI Operating marginPTPI Operating cash flowPTPI Free cash flowPTPI Capital expendituresPTPI Return on equityPTPI Stock buybacksPTPI Dividends paidPTPI Total assetsPTPI Total liabilitiesPTPI Shareholders’ equityPTPI overview →